Search Programme
Results for SOTA
Monday, September 21, 2026
-
13:30–15:00
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chair: Anne Floden (SE)
Driving excellence in transplant care: The role, vision and impact of the tts allied health committeeEstephan Arredondo (ES)Extending organ viability: The role of allied health in machine perfusion programsJoaquim Albiol (ES)Strategies to improve adherence after solid organ transplantationMariel Nöhre (DE)Panel discussionBronwyn Levvey (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chair: Ahmer Mohammad Hameed (AU)
Pancreas transplantation in type 2 diabetes mellitusPeter G. Stock (US)Diagnosis and treatment of pancreas rejectionPablo Uva (AR)Islets and stem cells in diabetes therapy: Current statusEelco de Koning (NL) -
13:30–15:00
Minimal Invasive Transplantation
Minimally invasive thoracic organ transplantationAlbert Jauregui (ES)Minimally invasive abdominal organ transplantationKwang Woong Lee (KR)Education and training strategies to safely disseminate robotic organ transplantationJinna Yao (AU)Future technological development in robotic organ transplantationDieter Broering (SA)
-
13:30–15:00
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
mNGS and rapid diagnostics: The next frontier in donor screening?Maricar Malinis (US)HIV-positive organ donation: Evolving guidelines and global perspectivesCameron Wolfe (US)MDRO: Cross-disciplinary approaches to donor-derived infection risk assessmentPriscilla Rupali (IN)Donors in the tropics and LMICs: What to consider?Siriorn Watcharananan (TH)
-
13:30–15:00
Using Technology to optimize outcomes of Liver Transplantation
Chair: Shantanu Bhattacharya (AU)
What does optimal use of HOPE and NMP look like?Carlo Pulitano (AU)Ischemia-free organ transplantationGuo Zhiyong (CN)The future for artificial Intelligence in liver transplantDorry Segev (US) -
13:30–15:00
Precision Immune Engineering in Kidney Transplantation
Next-generation co-stimulation blockadeCheng Yang (CN)Regulatory T-cell therapy 2.0: CAR-TregsMegan Levings (CA)Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantationMarta Crespo Barrio (ES)
-
13:30–15:00
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Global uterus transplantation activities and outcomes: the ISUTx registryMats Brännström (SE)Robotic surgery in uterus transplantationJean-Marc Ayoubi (FR)Setting up a uterus transplantation programRebecca Deans (AU)Updates on treatment and donor/recipient selectionPaige Porrett (US)
-
13:30–15:00
Harnessing the Power of Genetics in Pediatric Transplantation
Overview of genomic sequencing techniquesKatherine E. Twombley (US)When and why to consider genetic testing pre-transplantHugh McCarthy (AU)Bioethics in transplant gene testingAnne Priesz (AU)
-
13:30–15:00
How to combat transplant tourism
Chair: Thomas F. Müller (CH)
Patients traveling overseas for transplants - Practical experiencesAnantharaman Vathsala (SG)Challenges in registering unethical travel for transplant activitiesDominique Martin (AU)The living donor liver registryDimitri A. Raptis (SA)Tools to detect and report suspicious cases of traffickingMaria Amalia Matamoros (CR)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Senotherapy in transplantation
Global and local consequences of ‘environmental sciences’ on organ ageStefan Tullius (US)Cell-type and sex specific aspects of senescenceAnette Melk (DE)Aged immune systems drives organ agingMatthew Yousefzadeh (US)
-
13:30–15:00
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Equity and access in fragile health systems: A south asian perspectiveDivya Singh Shah (NP)
-
15:30–17:00
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair: John J. Fung (US)
The human face of standardsJohn J. Fung (US)Dignity for all: The human covenant: How the global essential standards protect every individual in the transplant encounterEfstratios (Stratos) Chatzixiros (CH)The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustainingMedhat Askar (QA)Stakeholders perspective from China: Translating standards into value for every actor in the ecosystemHaibo Wang (CN)Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystemHelen Opdam (AU)Connecting the circles: Panel discussionsDiscussion Period (AU)PanelistKaren Rockwell (GB)
Tuesday, September 22, 2026
-
13:30–15:00
Deceased Donation Research: Findings and Future Directions
Chair: Dominique Martin (AU)
Donor intervention studies – ethical and practical challengesDan Harvey (GB)Deceased donor physiological management researchGary F. Marklin (US)Thoracic ex-situ machine perfusion researchSarah Scheuer (AU)Biobanks for researchClaire Gordon (AU)Panel DiscussionDiscussion Period (AU) -
13:30–15:00
Targeting immune cell metabolism to control alloimmunity
How T cell metabolism regulates function and survivalCarl Atkinson (US)Treg metabolism and the impact of metabolites on their function and disease progressionLing Lu (CN)T cell landscapes following hematopoietic stem cell transplantationAntiopi Varelias (AU)
-
13:30–15:00
Artificial intelligence (AI) in Transplant Education
From concept to classroom: How to start using AI in transplant education?Susu Zughaier (QA)Mixed reality technology in organ transplantationAlfred Kow (SG)Panel DiscussionDiscussion Period (AU)
-
13:30–15:00
Transplanting Against the Antibody Odds
Chair: Ankit Sharma (AU)
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencingSandra Tafulo (PT)Crossing DSA in lung transplant: Is necessity the mother of invention?Kieran Halloran (CA)Immune memory responses: Unmasking the hidden antibody potentialGonca E. Karahan (NL)Organ allocation strategies for HLA compatibilityPhilip Andrew Clayton (AU) -
13:30–15:00
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chair: Animesh Singla (AU)
Novel outcome metrics in surgeryPierre-Alain Clavien (CH)Driving quality improvement through global surgical registriesDimitri A. Raptis (SA)Ensuring diversity in the transplant surgery workforceKendra Conzen (US) -
13:30–15:00
Biology and beyond: Multiple dimensions of transplantation
Chairs: Yolanda Becker (US); Philip O'Connell (AU)
Addressing gender disparity in access to pediatric kidney transplantation in IndiaKinnari Vala (IN)Social and cultural conflicts in uterine transplantationLimor Meoded Danon (IL)Impact of sex on cardiovascular outcomes after pediatric kidney transplantationRizky Indrameikha Sugianto (DE)Intersection of sex/gender, and cancer after transplantationBrenda Maria Rosales (AU) -
13:30–15:00
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Latest evidence on GLP-1s in transplantationBabak Orandi (US)Managing obesity without GLP-1s: Alternative strategiesAmanda Velazquez (US)Bariatric surgery in transplantation: Opportunities and challengesShashank R. Joshi (IN)Facilitating weight loss in individuals with frailty and sarcopeniaAstrid Ruiz-Margáin (MX)
-
13:30–15:00
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Chair: Toshio Miki (JP)
Pluripotent stem cells: Where are we in building new lungs?Rhiannon Werder (AU) -
13:30–15:00
Transplant Oncology: Peering Over the Horizon
Chair: Kwang Woong Lee (KR)
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?Julie Heimbach (US)Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?Takashi Ito (JP)Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possibleSudha Kodali (US)Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?Mohamed Rela (IN)Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?Seisuke Sakamoto (JP) -
13:30–15:00
Honouring voices, changing systems: Indigenous leadership in transplant equity
Chair: Jaquelyne Hughes (AU)
Building an indigenous lived experience database in organ donation and transplantationCaroline Tait (CA)Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New ZealandCurtis Walker (NZ)Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you MobStephen McDonald (AU)
Wednesday, September 23, 2026
-
13:45–15:15
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Chairs: Giuseppe Orlando (US); Ekaterine Berishvili-Berney (CH)
The bioartificial kidney: Lessons learned and the road aheadWilliam Fissell (CA)Organoids, organs-on-a-chip, and the path to organ manufacturingSean Vincent Murphy (US)Artificial heart: A life-saving bridge to transplantFrancisco Arabia (US) -
13:45–15:15
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Chair: Jen Li (AU)
Is there still a role for anti IL-6R in ABMR treatment?Roslyn B. Mannon (US)Is anti-CD38 the most promising agent for ABMR?Katharina Mayer (AT)What does monitoring AUC add compared to C-trough only?Teun van Gelder (NL)Model Informed precision dosingAnders Asberg (NO) -
13:45–15:15
Clinical Xenotransplantation has Arrived!
Understanding optimal genetic modificationPeter Cowan (AU)Experience and immunosuppression for clinical xenotransplantationRaphael Meier (US)Molecular analysis in clinical xenotransplantationCarmen Lefaucheur (FR)
-
13:45–15:15
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Chairs: Miranda Paraskeva (AU); Pablo Sanchez (US)
Debate 1: Pro normothermic regional perfusionAshish S. Shah (US)Debate 1: Pro ex vivo machine perfusionPeter MacDonald (AU)Debate 2: Pro ex vivo perfusionSandra Lindstedt Ingemansson (SE)Debate 2: Pro immediate transplantGregory I. Snell (AU)Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recoveryIrene Bello Rodriguez (ES)Panel DiscussionDiscussion Period (AU) -
13:45–15:15
State of VCA- Present and Future
Chairs: Patrik Lassus (FI); Hatem Amer (US)
Overview of VCA transplantsHatem Amer (US)VCA becoming part of universal health careDavid Leonard (GB)Is VCA reconstructive surgery or transplantationLinda C. Cendales (US)Challenges and opportunities for VCA in the global southSubramania Iyer (IN)Standardizing outcomes in VCA: Are we ready for a SONG or for COVERAllison Jaure (AU) -
13:45–15:15
Evolving Ethics and Emerging Trends in Transplantation
Chairs: David Thomson (ZA); Aviva Goldberg (CA)
Rating ourselves on the ethics of NRP - How are we doing?Anji Wall (US)Social media use in transplantationShaifali Sandal (CA)Ethical tissue sourcing for organoids: Why and HowKatrina Bramstedt (CH)Pediatric prioritizationThozama Siyotula (ZA)Retransplantation after nonadherence (adult & children)Aaron Wightman (US) -
13:45–15:15
Evolving strategies in intestinal and multivisceral transplantation
Chairs: Helen Evans (NZ); Rajith Amaratunga (AU)
Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonistYaron Avitzur (CA)Novel immunosuppression in intestine transplantationJennifer Garcia (US)Pros and cons of protocol biopsy and stomaJonathan Hind (AU) -
13:45–15:15
Diversity, Equity, and Inclusion in Gender and Transplantation
Regional and gender disparities in abstracts presented at international transplant congressMaggie Kam Man Ma (HK)Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantationElmi Muller (ZA)Redefining equity: Women, access, and outcomes in liver transplantationGomathy Narasimhan (IN)
-
13:45–15:15
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Shared framework for living donor evaluation: medical, psychosocial, and ethical coreKrista Lentine (US)Surgical challenges and functional outcomes in living kidney donationMireia Musquera (ES)Surgical challenges and functional outcomes in living liver donationDongJin Joo (KR)Predictive models and global registry insights to enhance donor safetyAllan Massie (US)
-
13:45–15:15
Innovations in skin cancer in transplantation
Chairs: Angela Webster (AU); Brenda Maria Rosales (AU)
Skin cancer risk prediction and communicationAnne Cust (AU)Complex surgical oncologyAlexander Varey (AU)Novel developments in keratinocyte cancer treatments in AustraliaKiarash Khosrotehrani (AU)Panel DiscussionDiscussion Period (AU)